Integrating Real-World Evidence in Rare Disease Clinical Trials
Integrating Real-World Evidence in Rare Disease Clinical Trials Harnessing Real-World Evidence for Rare Disease Clinical Trial Success Why Real-World Evidence Matters in Rare Disease Studies Rare disease trials often face unique challenges—small sample sizes, heterogeneous patient populations, and ethical concerns with placebo use. Real-world evidence (RWE), derived from electronic health records (EHRs), patient registries, insurance…
Read More “Integrating Real-World Evidence in Rare Disease Clinical Trials” »
